ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT NOVEMBER 2024

Zinzino group revenue increased with a total of 26 %, compared with the previous year.

The revenue in November for Zinzino's sales markets increased by 26 % and amounted to SEK 252.7 (201.1) million. Faun Pharma's external sales increased by 33 % and amounted to SEK 10.0 (7.5) million. Overall, the Group increased revenues by 26 % to SEK 262.7 (208.6) million compared with the previous year.

Accumulated revenue for January – November 2024 increased by 21 % to SEK 1955.9 (1611.0) million.

Revenues were distributed as follows:

Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, www.zinzino.com

Pictures for publication free of charge: marketing@zinzino.com

Certified Adviser: Carnegie Investment Bank AB (publ.)